The Stroke Hyperglycaemia Insulin Network Effect (SHINE) randomised trial [29] attempted to circumvent this challenge by using differing cut off glucose values for recruitment: > 6.1mmol/L for those with known diabetes, and > 8.3mmol/L for those without diabetes. The gene discussed is INS; the disease is diabetes mellitus.